Search research articles
Contact Us
Filters
Showing results (1-10 of 185) with videos related to
Page
of 19
Sort By:
Journal of Genetic Counseling
|
May 28, 2016
The Impact of Angelina Jolie (AJ)'s Story on Genetic Referral and Testing at an Academic Cancer Centre in Canada
Jacques Raphael, Sunil Verma, Paul Hewitt, et al.
Cancer Treatment Reviews
|
January 1, 2008
Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review
Andrea Eisen, Maureen Trudeau, Wendy Shelley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2009
Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene
Tao Deng, Jeff C Liu, Kathleen I Pritchard, et al.
JCO Oncology Practice
|
November 12, 2024
Clinical Management of Ovarian Function Suppression in Premenopausal Women With Breast Cancer: A Survey of Members of ASCO
Catherine M Kelly, Kathleen E Bennett, Caitriona Cahir, et al.
Cancer Medicine
|
September 30, 2025
Impact of Immigration Status on Survival Among Stage 1 and 2 HER2-Positive and Triple-Negative Breast Cancer in Ontario, Canada
Omolara Fatiregun, Rinku Sutradhar, Sho Podolsky, et al.
Journal of Health Psychology
|
March 19, 2011
The symptom appraisal of breast cancer in the context of an intimate relationship
Karen Fergus, Barbara Fitzgerald, Leeat Granek, et al.
Annals of Internal Medicine
|
May 7, 2008
Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer
Ellen Warner, Hans Messersmith, Petrina Causer, et al.
Plos One
|
June 21, 2017
Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancer
Jeffrey C Liu, Miriam Zacksenhouse, Andrea Eisen, et al.
Clinical Breast Cancer
|
August 17, 2025
Appropriate Treatment for Stage 1 and 2 Her2-Positive and Triple-Negative Breast Cancer by Immigration Status in Ontario, Canada
Omolara Fatiregun, Rinku Sutradhar, Sho Podolsky, et al.
Breast Cancer Research and Treatment
|
January 24, 2021
Factors associated with waiting time to breast cancer diagnosis among symptomatic breast cancer patients: a population-based study from Ontario, Canada
Colleen Webber, Marlo Whitehead, Andrea Eisen, et al.
Page
of 19
Search research articles
Search
Showing results (1-10 of 185) with videos related to
Sort By:
Page
of 19
Journal of Genetic Counseling
|
May 28, 2016
The Impact of Angelina Jolie (AJ)'s Story on Genetic Referral and Testing at an Academic Cancer Centre in Canada
Jacques Raphael, Sunil Verma, Paul Hewitt, et al.
Cancer Treatment Reviews
|
January 1, 2008
Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review
Andrea Eisen, Maureen Trudeau, Wendy Shelley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2009
Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene
Tao Deng, Jeff C Liu, Kathleen I Pritchard, et al.
JCO Oncology Practice
|
November 12, 2024
Clinical Management of Ovarian Function Suppression in Premenopausal Women With Breast Cancer: A Survey of Members of ASCO
Catherine M Kelly, Kathleen E Bennett, Caitriona Cahir, et al.
Cancer Medicine
|
September 30, 2025
Impact of Immigration Status on Survival Among Stage 1 and 2 HER2-Positive and Triple-Negative Breast Cancer in Ontario, Canada
Omolara Fatiregun, Rinku Sutradhar, Sho Podolsky, et al.
Journal of Health Psychology
|
March 19, 2011
The symptom appraisal of breast cancer in the context of an intimate relationship
Karen Fergus, Barbara Fitzgerald, Leeat Granek, et al.
Annals of Internal Medicine
|
May 7, 2008
Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer
Ellen Warner, Hans Messersmith, Petrina Causer, et al.
Plos One
|
June 21, 2017
Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancer
Jeffrey C Liu, Miriam Zacksenhouse, Andrea Eisen, et al.
Clinical Breast Cancer
|
August 17, 2025
Appropriate Treatment for Stage 1 and 2 Her2-Positive and Triple-Negative Breast Cancer by Immigration Status in Ontario, Canada
Omolara Fatiregun, Rinku Sutradhar, Sho Podolsky, et al.
Breast Cancer Research and Treatment
|
January 24, 2021
Factors associated with waiting time to breast cancer diagnosis among symptomatic breast cancer patients: a population-based study from Ontario, Canada
Colleen Webber, Marlo Whitehead, Andrea Eisen, et al.
Page
of 19